These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7342286

  • 1. Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function.
    Moellering RC, Krogstad DJ, Greenblatt DJ.
    Rev Infect Dis; 1981; 3 suppl():S230-5. PubMed ID: 7342286
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of vancomycin in anuria.
    Cunha BA, Quintiliani R, Deglin JM, Izard MW, Nightingale CH.
    Rev Infect Dis; 1981; 3 suppl():S269-72. PubMed ID: 7342290
    [Abstract] [Full Text] [Related]

  • 3. Clinical pharmacokinetics of vancomycin.
    Matzke GR, Zhanel GG, Guay DR.
    Clin Pharmacokinet; 1986; 11(4):257-82. PubMed ID: 3530582
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
    Strid S, Borgå O, Edenius C, Jostell KG, Odergren T, Weil A.
    Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
    Welink J, Boven E, Vermorken JB, Gall HE, van der Vijgh WJ.
    Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
    [Abstract] [Full Text] [Related]

  • 6. Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis.
    Ayus JC, Eneas JF, Tong TG, Benowitz NL, Schoenfeld PY, Hadley KL, Becker CE, Humphreys MH.
    Clin Nephrol; 1979 Mar; 11(3):129-32. PubMed ID: 436339
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J, Tutor JC.
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [Abstract] [Full Text] [Related]

  • 9. Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine.
    Kildoo CW, Lin LM, Gabriel MH, Folli HL, Modanlou HD.
    Dev Pharmacol Ther; 1989 Jun; 14(2):77-83. PubMed ID: 2630235
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Initial dosage of vancomycin in neutropenic hematologic patients].
    Soto J, Alsar MJ, Sacristán JA.
    Sangre (Barc); 1992 Jun; 37(3):181-4. PubMed ID: 1440095
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of fleroxacin in renal impairment.
    Weidekamm E.
    Am J Med; 1993 Mar 22; 94(3A):70S-74S. PubMed ID: 8452185
    [Abstract] [Full Text] [Related]

  • 13. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH.
    Clin Ther; 2007 Jun 22; 29(6):1107-15. PubMed ID: 17692725
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage.
    Matzke GR, Kovarik JM, Rybak MJ, Boike SC.
    Clin Pharm; 1985 Jun 22; 4(3):311-5. PubMed ID: 4006395
    [Abstract] [Full Text] [Related]

  • 17. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
    Hutschala D, Kinstner C, Skhirdladze K, Thalhammer F, Müller M, Tschernko E.
    Anesthesiology; 2009 Aug 22; 111(2):356-65. PubMed ID: 19602966
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.
    Tanaka A, Suemaru K, Otsuka T, Ido K, Nishimiya T, Sakai I, Hasegawa H, Inoue T, Murase M, Yasukawa M, Araki H.
    Ther Drug Monit; 2007 Apr 22; 29(2):261-4. PubMed ID: 17417082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.